NCT01676324View on ClinicalTrials.gov

FOCUS: The Future of Fecal Calprotectin Utility Study for the Diagnosis and Management of Inflammatory Bowel Disease (IBD)

CompletedOBSERVATIONAL
Enrollment

289

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

September 30, 2013

Conditions
Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis
Trial Locations (1)

V6Z 2K5

GI Research Institute (GIRI), Vancouver

All Listed Sponsors
lead

University of British Columbia

OTHER

NCT01676324 - FOCUS: The Future of Fecal Calprotectin Utility Study for the Diagnosis and Management of Inflammatory Bowel Disease (IBD) | Biotech Hunter | Biotech Hunter